Premium
Delayed Onset of Angioedema with Angiotensin‐Converting Enzyme Inhibitors: Case Report and Review of the Literature
Author(s) -
O'Mara Neeta Bahal,
O'Mara Edward M.
Publication year - 1996
Publication title -
pharmacotherapy: the journal of human pharmacology and drug therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.227
H-Index - 109
eISSN - 1875-9114
pISSN - 0277-0008
DOI - 10.1002/j.1875-9114.1996.tb03651.x
Subject(s) - angioedema , medicine , angiotensin converting enzyme , bradykinin , benazepril , myocardial infarction , hereditary angioedema , heart failure , ace inhibitor , cardiology , renin–angiotensin system , dermatology , blood pressure , receptor
The angiotensin‐converting enzyme inhibitors have gained widespread application in the management of hypertension and congestive heart failure, and after myocardial infarction. They are generally considered safe drugs, but there are a number of reports of angioedema associated with their use. In general, angioedema occurs within hours to days after initiation of therapy, and only a limited number of reports document a delayed onset. Our patient experienced angioedema after 14 months of therapy with benazepril.